Ester Miralpeix

567 total citations
20 papers, 364 citations indexed

About

Ester Miralpeix is a scholar working on Surgery, Epidemiology and Oncology. According to data from OpenAlex, Ester Miralpeix has authored 20 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 8 papers in Epidemiology and 6 papers in Oncology. Recurrent topics in Ester Miralpeix's work include Cervical Cancer and HPV Research (8 papers), Enhanced Recovery After Surgery (5 papers) and Cardiac, Anesthesia and Surgical Outcomes (5 papers). Ester Miralpeix is often cited by papers focused on Cervical Cancer and HPV Research (8 papers), Enhanced Recovery After Surgery (5 papers) and Cardiac, Anesthesia and Surgical Outcomes (5 papers). Ester Miralpeix collaborates with scholars based in Spain, Vietnam and United Kingdom. Ester Miralpeix's co-authors include Gemma Mancebo, Josep‐Maria Solé‐Sedeño, Ramón Carreras, Maria D. Iniesta, Juan P. Cata, Pedro T. Ramírez, Vijaya Gottumukkala, Javier Lasala, Alpa M. Nick and Gloria Salvo and has published in prestigious journals such as Scientific Reports, International Journal of Environmental Research and Public Health and Gynecologic Oncology.

In The Last Decade

Ester Miralpeix

19 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ester Miralpeix Spain 10 198 112 111 83 79 20 364
Aykut Özdemir Türkiye 11 112 0.6× 42 0.4× 29 0.3× 37 0.4× 96 1.2× 24 298
C. Dalrymple Australia 8 113 0.6× 41 0.4× 25 0.2× 132 1.6× 84 1.1× 19 283
Caiyun Liao United States 8 58 0.3× 80 0.7× 26 0.2× 49 0.6× 53 0.7× 15 323
Arthur L. Herbst United States 7 106 0.5× 39 0.3× 29 0.3× 55 0.7× 81 1.0× 9 279
Gökhan Demirayak Türkiye 11 90 0.5× 38 0.3× 21 0.2× 27 0.3× 83 1.1× 33 288
Rafli van de Laar Netherlands 10 108 0.5× 26 0.2× 10 0.1× 65 0.8× 133 1.7× 16 274
Berna Aslan Çetin Türkiye 11 95 0.5× 34 0.3× 24 0.2× 59 0.7× 41 0.5× 66 368
I. Rákóczi Hungary 10 66 0.3× 22 0.2× 32 0.3× 42 0.5× 35 0.4× 22 402
Önder Ercan Türkiye 11 51 0.3× 58 0.5× 42 0.4× 35 0.4× 152 1.9× 28 387
Bülent Köstü Türkiye 10 55 0.3× 62 0.6× 40 0.4× 27 0.3× 150 1.9× 32 392

Countries citing papers authored by Ester Miralpeix

Since Specialization
Citations

This map shows the geographic impact of Ester Miralpeix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ester Miralpeix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ester Miralpeix more than expected).

Fields of papers citing papers by Ester Miralpeix

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ester Miralpeix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ester Miralpeix. The network helps show where Ester Miralpeix may publish in the future.

Co-authorship network of co-authors of Ester Miralpeix

This figure shows the co-authorship network connecting the top 25 collaborators of Ester Miralpeix. A scholar is included among the top collaborators of Ester Miralpeix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ester Miralpeix. Ester Miralpeix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mancebo, Gemma, et al.. (2025). Influence of Age on Treatment and Prognosis in Ovarian Cancer Patients. Cancers. 17(9). 1397–1397.
2.
Miralpeix, Ester, et al.. (2024). Pre-operative impact of multimodal prehabilitation in gynecologic oncology patients. International Journal of Gynecological Cancer. 35(2). 100062–100062. 1 indexed citations
3.
Solé‐Sedeño, Josep‐Maria, et al.. (2023). Protein Supplementation in a Prehabilitation Program in Patients Undergoing Surgery for Endometrial Cancer. International Journal of Environmental Research and Public Health. 20(8). 5502–5502. 6 indexed citations
4.
Miralpeix, Ester, et al.. (2023). Prehabilitation in an ERAS program for endometrial cancer patients: impact on post-operative recovery. International Journal of Gynecological Cancer. 33(4). 528–533. 11 indexed citations
5.
Miralpeix, Ester, et al.. (2022). Impact of prehabilitation during neoadjuvant chemotherapy and interval cytoreductive surgery on ovarian cancer patients: a pilot study. World Journal of Surgical Oncology. 20(1). 46–46. 28 indexed citations
6.
Mancebo, Gemma, Ester Miralpeix, Josep‐Maria Solé‐Sedeño, et al.. (2021). Influence of age on treatment and prognosis of invasive cervical cancer. European Journal of Obstetrics & Gynecology and Reproductive Biology. 262. 68–72. 1 indexed citations
7.
Miralpeix, Ester, et al.. (2021). Predictor factors for conservative management of cervical intraepithelial neoplasia grade 2: Cytology and HPV genotyping. Gynecologic Oncology. 162(3). 569–574. 19 indexed citations
8.
Mancebo, Gemma, Josep‐Maria Solé‐Sedeño, I. Membrive, et al.. (2020). Gynecologic cancer surveillance in the era of SARS-CoV-2 (COVID-19). International Journal of Gynecological Cancer. 31(6). 914–919. 23 indexed citations
9.
Miralpeix, Ester, et al.. (2019). Role and impact of multimodal prehabilitation for gynecologic oncology patients in an Enhanced Recovery After Surgery (ERAS) program. International Journal of Gynecological Cancer. 29(8). 1235–1243. 44 indexed citations
10.
Miralpeix, Ester, Josep‐Maria Solé‐Sedeño, Sílvia Agramunt, et al.. (2019). Role of Chlamydia trachomatis serology in conservative management of cervical intraepithelial neoplasia grade 2. International Journal of Gynecology & Obstetrics. 147(1). 43–48. 4 indexed citations
11.
Miralpeix, Ester, et al.. (2018). Prognostic nutritional index predicts postoperative outcome in ovarian cancer. Clinical Nutrition ESPEN. 25. 180–180. 1 indexed citations
12.
Mancebo, Gemma, Josep‐Maria Solé‐Sedeño, Ester Miralpeix, et al.. (2017). Prognostic impact of CD133 expression in Endometrial Cancer Patients. Scientific Reports. 7(1). 7687–7687. 9 indexed citations
13.
Solé‐Sedeño, Josep‐Maria, Gemma Mancebo, Ester Miralpeix, et al.. (2017). Utility of Human Papillomavirus Genotyping in the Management of Low-Grade Squamous Intraepithelial Lesions. Journal of Lower Genital Tract Disease. 22(1). 13–16. 10 indexed citations
14.
Miralpeix, Ester, Alpa M. Nick, Larissa A. Meyer, et al.. (2016). A call for new standard of care in perioperative gynecologic oncology practice: Impact of enhanced recovery after surgery (ERAS) programs. Gynecologic Oncology. 141(2). 371–378. 111 indexed citations
15.
Miralpeix, Ester, Josep‐Maria Solé‐Sedeño, Gemma Mancebo, et al.. (2016). Usefulness of p16INK4a staining for managing histological high-grade squamous intraepithelial cervical lesions. Modern Pathology. 30(2). 304–310. 42 indexed citations
16.
Miralpeix, Ester, Josep‐Maria Solé‐Sedeño, Gemma Mancebo, et al.. (2016). Value of p16(INK4a) and Ki-67 Immunohistochemical Staining in Cervical Intraepithelial Neoplasia Grade 2 Biopsies as Biomarkers for Cervical Intraepithelial Neoplasia Grade 3 in Cone Results.. PubMed. 38(1). 1–8. 4 indexed citations
17.
Mancebo, Gemma, Ester Miralpeix, B. Lloveras, et al.. (2015). Utility of HPV genotyping in the management of low-grade squamous intraepithelial cervical lesions (LSIL). Gynecologic Oncology. 137. 31–31. 1 indexed citations
18.
Miralpeix, Ester, Gemma Mancebo, B. Lloveras, et al.. (2015). Predictive value of p16INK4a and Ki-67 immunohistochemical staining in expectant management of cervical intraepithelial neoplasia grade 2. Gynecologic Oncology. 137. 27–28. 1 indexed citations
19.
Miralpeix, Ester, et al.. (2014). Alcohol consumption andin vitrofertilization: a review of the literature. Gynecological Endocrinology. 30(11). 759–763. 18 indexed citations
20.
Miralpeix, Ester, Mireia González-Comadran, Iván Solà, et al.. (2013). Efficacy of luteal phase support with vaginal progesterone in intrauterine insemination: a systematic review and meta-analysis. Journal of Assisted Reproduction and Genetics. 31(1). 89–100. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aykut Özdemir Breakdown of academic impact, for papers by C. Dalrymple Breakdown of academic impact, for papers by Caiyun Liao Breakdown of academic impact, for papers by Arthur L. Herbst Breakdown of academic impact, for papers by Gökhan Demirayak Breakdown of academic impact, for papers by Rafli van de Laar Breakdown of academic impact, for papers by Berna Aslan Çetin Breakdown of academic impact, for papers by I. Rákóczi Breakdown of academic impact, for papers by Önder Ercan Breakdown of academic impact, for papers by Bülent Köstü
Rankless by CCL
2026